![Ann Zahle Andersen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ann Zahle Andersen
Fondateur chez
GlyProVac ApS
Technology Services
Profil
Ann Zahle Andersen is the founder of GlyProVac ApS, established in 2018.
Dr. Andersen holds the title of Chief Operating Officer at GlyProVac ApS.
Postes actifs de Ann Zahle Andersen
| Sociétés | Poste | Début |
|---|---|---|
GlyProVac ApS
 GlyProVac ApS Packaged SoftwareTechnology Services Develops bacterial glycoprotein antigens technology for vaccine development | Fondateur | 01/01/2018 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
GlyProVac ApS
GlyProVac ApS Packaged SoftwareTechnology Services Develops bacterial glycoprotein antigens technology for vaccine development | Technology Services |
